Data / Form D filings / Groff North America, LLC
Groff North America, LLC: Form D filing
Groff North America, LLC, a pharmaceuticals company in Red Lion, PA, filed a Form D with the SEC in 2023. The latest, on July 14, 2023, reports $13.1 million sold of a $17.6 million offering to 24 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 REDCO AVE, SUITE A, Red Lion, PA, 17356
- Phone
- (717) 741-8446
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Pennsylvania
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1985457
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 14, 2023 | New notice | $17,598,333 | $13,098,333 | $4,500,000 | 24 | Jun 30, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert A. Kinsley, II | Executive Officer |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Groff North America, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.